Leslie Floren, PharmD, PhD, MA
Professor
Clinical Pharmacy
School of Pharmacy

leslie.floren@ucsf.edu 415-514-3559

Leslie Carstensen Floren, PharmD, DABCP is an Associate Adjunct Professor of Bioengineering and Therapeutic Sciences (BTS) in the School of Pharmacy at UCSF, the Academic Coordinator and Director of Professional and Postdoctoral Educational Affairs in BTS as well as the co-Director of the NIH-funded, UCSF Clinical Pharmacology Fellowship Training Program.

Show full bio (220 words) Hide full bio

Her teaching responsibilities for the past several years have included, primarily, teaching pharmacokinetics/pharmacodynamics, clinical pharmacology and principles of drug development and regulatory sciences to a wide variety of students, including professional students in the PharmD program, Clinical Pharmacology Fellows, junior faculty members, and working professionals from industrial backgrounds. Teaching is one of her greatest pleasures and she has been honored to receive the School of Pharmacy Dean’s Recognition for Excellence in Teaching every year since 2005 and, in 2010, she received the highest honor in the School of Pharmacy for teaching, the Long Award for Excellence in Teaching. Dr. Floren has a keen interest in curriculum development, teaching methodology and assessment, educational technology and online education and will begin training in the School of Medicine 2012-2013 Teaching Scholars Program in order to develop innovative curricula, to implement novel teaching methods and to use technology in order to “bring to life” the principles of Pharmacokinetics, Pharmacodynamics and Clinical Pharmacology for a wide variety of students within and across disciplines and, ultimately, to have a positive impact on patient health. She also plans to conduct scholarly research that will demonstrate the utility of practice-based teaching methods in order to advance interdisciplinary pharmaceutical sciences education within UCSF, our local community and across the country.

Awards

Show all (4) Hide

  • UCSF Teaching Scholars Program, 2012
  • Long Award for Excellence in Teaching, 2010
  • UCSF School of Pharmacy Dean’s Recognition for Excellence in Teaching, 2005-2012
  • Postdoctoral Research Fellowship, Department of Biopharmaceutical Sciences, UCSF, 1995-1997

Education & Training

Show all (5) Hide

  • Diversity, Equity, and Inclusion Champion Training University of California 11/2020
  • MA Health Professions Education University of California 12/2013
  • Post-Doc Fellow/Scholar School of Pharmacy University of California 1997
  • Pharm.D. School of Pharmacy University of California 1994
  • Residency School of Pharmacy University of California

Websites

Show all (1) Hide

Grants and Projects

Show all (1) Hide

Publications (25)

Top publication keywords:
Interprofessional RelationsHealth EducationProfessional RoleStudents, Health OccupationsPatient Care TeamPharmacology, ClinicalLearningEducation, DistanceHealth OccupationsStudents, MedicalEducation, ProfessionalCooperative BehaviorHealth PersonnelStudents, PharmacyEducation, Pharmacy

Show all (20 more) Hide

  • A Mobile Learning Module to Support Interprofessional Knowledge Construction in the Health Professions.
    American journal of pharmaceutical education 2020 Floren LC, Mandal J, Dall'Era M, Shin J, Irby DM, Cate OT, O'Brien BC
  • Clinical Pharmacology Education - The Decade Ahead.
    Clinical pharmacology and therapeutics 2019 Brouwer KLR, Schmidt S, Floren LC, Johnson JA
  • A review of interprofessional training wards: Enhancing student learning and patient outcomes.
    Medical teacher 2018 Oosterom N, Floren LC, Ten Cate O, Westerveld HE
  • Are We on the Same Page? Shared Mental Models to Support Clinical Teamwork Among Health Professions Learners: A Scoping Review.
    Academic medicine : journal of the Association of American Medical Colleges 2018 Floren LC, Donesky D, Whitaker E, Irby DM, Ten Cate O, O'Brien BC
  • Changes in clearance, volume and bioavailability of immunosuppressants when given with HAART in HIV-1 infected liver and kidney transplant recipients.
    Biopharmaceutics & drug disposition 2013 Frassetto L, Floren L, Barin B, Browne M, Wolfe A, Roland M, Stock P, Carlson L, Christians U, Benet L
  • Cancer Chemother Pharmacol
    Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon alpha-2b in patients with resected high-risk melanoma. 2011 Daud AI, Xu C, Hwu WJ, Urbas P, Andrews S, Papadopoulos NE, Floren LC, Yver A, Deconti RC, Sondak VK.
  • Br J Cancer
    Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma. 2010 DeConti RC, Algazi AP, Andrews S, Urbas P, Born O, Stoeckigt D, Floren L, Hwang J, Weber J, Sondak VK, Daud AI.
  • Drug Metab Dispos
    An Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple Dosing. 2009 GR Tonn, SG Wong, SC Wong, MG Johnson, J Ma, R Cho, LC Floren, K Kersey, K Berry, AP Marcus, X Wang, B Van Lengerich, JC Medina, PG Pearson, and BK Wong.
  • Safety and pharmacokinetics (PK) of T138067 (T67) administered as a weekly 3-hour infusion in subjects with hepatocellular carcinoma (HCC) in a phase 1 study.
    Journal of Clinical Oncology 2004 A. P. Venook, E. K. Rowinsky, R. C. Donehower, T. Leung, L. C. Floren, M. Levy
  • Safety and pharmacokinetics (PK) of T138067 (T67) administered as a weekly 3-hour infusion in subjects with hepatocellular carcinoma (HCC) in a phase 1 study.
    Journal of Clinical Oncology 2004 A. P. Venook, E. K. Rowinsky, R. C. Donehower, T. Leung, L. C. Floren, M. Levy
  • Drug Metab Pharmacokinet
    Pharmacokinetic Interactions between Cyclosporine and Protease Inhibitors in HIV+ Subjects. 2003 LA Frassetto, Thai T, Aggarwal A, Bucher P, Jacobsen W, U Christians, LZ Benet, LC Floren.
  • Pediatrics
    Nelfinavir pharmacokinetics in stable HIV-positive children: AIDS Clinical Trials Group Protocol 377. 2003 LC Floren, A Wiznia , SA Hayashi, A Jaywardene, K Stanley, G Johnson, S Nachman, P Krosstad, F Aweeka.
  • Clin Pharmacol Ther
    The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups. 2001 L Mancinelli, L Frassetto, LC Floren, D Dressler, S Carrier, I Bekersky, LZ Benet, U Christians.
  • Sirolimus oral bioavailability increases ten-fold with concomitant ketoconazole.
    Clinical Pharmacology & Therapeutics 1999 L.C. Floren, U. Christians, J.J. Zimmerman, L. Neefe, R. Schorer, D. Rushworth, D. Harper, J. Renz, L.Z. Benet
  • Ann Onc
    Tamoxifen in liver disease: potential exacerbation of hepatic function. 1998 LC Floren, MF Hebert, AP Venook, VC Jordan, A Cisneros, and KA Somberg.
  • CJHP
    Pharmacogenetics: The clinical significance of cytochrome P450 polymorphisms. 1998 C Cheng and LC Floren.
  • Pharmacol Ther
    Metabolism and drug interactions of the 3-hydroxy-3methylglutaryl Coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar? 1998 U Christians, W Jacobsen and LC Floren.
  • Clin Pharmacol Ther
    Tacrolimus oral bioavailability doubles with co-administration of ketoconazole. 1997 LC Floren, I Bekersky, LZ Benet, QA Mekki, DE Dressler, JW Lee, JP Roberts, and MF Hebert.
  • Transplantationsmedizen
    The clinical pharmacokinetics of macrolide immunosuppressants and its impact on the clinical management of organ transplantation. 1997 U Christians, LC Floren, G Kirchner, and K-F Sewing.
  • Foscarnet Pharmacokinetics (PK) During Continuous Ambulatory Peritoneal Dialysis (CAPD).
    Clinical Pharmacology & Therapeutics 1996 L. Floren, J.G. Gambertoglio, S. Martin-Munley, F. Aweeka